TrialJournal of translational medicine2017

Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study.

Luis de la Cruz-Merino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.